Trial Profile
A phase III trial of Doranidazole, combined with intra-operative radiation therapy for pancreatic cancer.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 21 Aug 2017
Price :
$35
*
At a glance
- Drugs Doranidazole (Primary)
- Indications Pancreatic cancer
- Focus Therapeutic Use
- 21 Aug 2017 New trial record